 | This articlerelies largely or entirely on asingle source. Relevant discussion may be found on thetalk page. Please helpimprove this article byintroducing citations to additional sources. Find sources: "Buscaline" – news ·newspapers ·books ·scholar ·JSTOR(August 2019) |
 | |
 | |
| Clinical data | |
|---|---|
| Other names | B; 3,5-Dimethoxy-4-butoxyphenethylamine; 4-Butoxy-3,5-dimethoxyphenethylamine |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Several hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C14H23NO3 |
| Molar mass | 253.342 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Buscaline (B), also known as4-butoxy-3,5-dimethoxyphenethylamine, is achemical compound prepared as a possiblepsychedelic drug.[1] It is ananalogue ofmescaline. Buscaline was firstsynthesized byAlexander Shulgin.[1] In his bookPiHKAL (Phenethylamines I Have Known and Loved), the minimum dose is listed as 150 mg, and theduration as "several hours".[1] Buscaline produced no clearhallucinogenic effects, but causedside effects likeheart arrhythmia and lightdiarrhea.[1] It did not cause anyvisuals orinsights.[1]
 | Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |
